In prostate cancer, genetic and pharmacological inhibitions of OGT sensitize the cells to apoptosis induced by docetaxel, an anti-cancer drug that inhibits depolymerization of microtubules and cell division (200). The gene discussed is OGT; the disease is Familial prostate cancer.